Moderna Starts Human Trial of mRNA Vaccine Against Bundibugyo Ebola 3 months ago AnaIn Breaking NewsClinical TrialsFeatured AnalysisInnovationTop Stories
China’s Biotech Model Is Moving From Asset Export to Integrated Drug Building 3 months ago AnaIn AI & DataBiopharma ManufacturingFeatured AnalysisInnovationPartnershipsTop Stories
The Biohaven Verdict Sends a Warning Through Biotech’s Confidential Deal Rooms 3 months ago AnaIn Featured AnalysisPartnershipsPharma Industry UpdatesTop StoriesVenture Capital
Bambusa’s Dual-Target Antibody Shows Early Atopic Dermatitis Activity After First Dose 3 months ago AnaIn Breaking NewsClinical TrialsInnovationResearch Updates
IDEAYA Expands IDE892 Study in MTAP-Deleted Pancreatic and Lung Cancers 3 months ago AnaIn Biopharma HighlightsClinical TrialsInnovationResearch Updates
Novo Nordisk Escalates Ad War With Lilly, Seeks Court Order Over Dosing Comparisons 4 months ago AnaIn Pharma Industry UpdatesTop Stories
MannKind Wins FDA Approval for Furoscix ReadyFlow, Cutting Heart Failure Diuretic Therapy From Five Hours to Ten Seconds 4 months ago AnaIn Breaking NewsFDA ApprovalsInnovation
The Tariff Deadline Reshaping Where Pharma Makes Its Drugs 4 months ago AnaIn Biopharma ManufacturingFeatured AnalysisPharma Industry UpdatesTop Stories
Global CRO Market on Pace to Reach $140 Billion by 2031 as Sponsors Lean Harder on Outsourced Trial Capacity 4 months ago AnaIn AI & DataBiopharma HighlightsPharma Industry Updates
Drug Farm Raises $55 Million Series D to Advance Dual-Indication ALPK1 Programs 4 months ago AnaIn Clinical TrialsFunding RoundsVenture Capital
Inside the Fight Over Sean Kaufman: What a Vaccine Skeptic’s Nomination Reveals About HHS’s Next Chapter 4 months ago AnaIn Breaking NewsLeadersPharma Industry UpdatesTop Stories
ProMIS Neurosciences Reports First Human Evidence of Dose-Dependent Amyloid-Oligomer Reduction at AAIC 2026 4 months ago AnaIn BreakthroughsClinical TrialsResearch Updates
Biotech M&A Roars Back: Why 2026 Is Already the Best Dealmaking Year in Seven Years 4 months ago AnaIn Featured AnalysisPartnershipsTop StoriesVenture Capital
Bausch + Lomb Discontinues Glaucoma Eye Drop Program After Phase 2 Trial Misses Primary Endpoint 4 months ago AnaIn Clinical TrialsPharma Industry Updates
Q32 Bio Reports 36-Week Data From Expanded Alopecia Areata Trial, Advancing Bempikibart Toward Pivotal Studies 4 months ago AnaIn Breaking NewsClinical TrialsFeatured AnalysisTop Stories
